Its also important to talk about your weight loss goals, changes in your menstrual cycle, and your long-term health plan
What is the intended use of this product
Published online 2015 Jan 22
NICE guidance (NG28) recommends regular review of patients on GLP-1 receptor agonists, typically at around 6 months, to assess treatment response
Your healthcare provider will conduct a thorough evaluation including medical history, physical examination, and potentially laboratory tests (such as inflammatory markers, rheumatoid factor, or uric acid levels) or imaging studies (radiographs, ultrasound, or MRI) to establish the diagnosis
In fact, weight loss through semaglutide can help lower the risk of heart attacks and strokes, so it is beneficial for many people